| Date | Time | Source | Headline | Symbol | Company |
| 26/03/2013 | 13:31 | PR Newswire (US) | Critical Alerts For Lowe's, Apollo Group, Darden Restaurants, Onyx Pharmaceuticals, and Ocwen Financial Released By Investors... | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 26/03/2013 | 13:17 | Dow Jones News | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 26/03/2013 | 10:54 | Dow Jones News | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 25/03/2013 | 21:16 | PR Newswire (US) | Bayer's Stivarga® (regorafenib) Tablets Approved in Japan | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 21/03/2013 | 19:40 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 18/03/2013 | 12:00 | PR Newswire (US) | Innovative Product Portfolios Ride Commercialization & Global Expansion - Research Report on Amgen, Onyx Pharmaceuticals, Ale... | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 15/03/2013 | 19:52 | Dow Jones News | UPDATE: Onyx Pharmaceuticals CEO: Seeking Acquisition Targets | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 15/03/2013 | 16:40 | Dow Jones News | Onyx Pharmaceuticals CEO: Seeking Acquisition Targets | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 13/03/2013 | 23:44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 13/03/2013 | 23:41 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 13/03/2013 | 23:38 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 13/03/2013 | 23:37 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 12/03/2013 | 14:00 | Marketwired | Perfect Trade Setups, How to Play NKE, CCL, LMT and ONXX | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 12/03/2013 | 14:00 | GlobeNewswire Inc. | ONYX Pharmaceuticals, Inc. [ONXX] to Ring The NASDAQ Stock Market Opening Bell | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 11/03/2013 | 21:51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 11/03/2013 | 21:50 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 11/03/2013 | 21:48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 11/03/2013 | 12:43 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 04/03/2013 | 23:40 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 28/02/2013 | 22:20 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 27/02/2013 | 21:00 | Marketwired | Onyx Pharmaceuticals to Host Analyst Day March 14, 2013 | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 25/02/2013 | 21:05 | PR Newswire (US) | Bayer's Stivarga® (regorafenib) Tablets Approved by U.S. FDA for Treatment of Patients with Locally Advanced, Unresectable o... | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 22/02/2013 | 11:40 | Zacks | Onyx Tops Expectations - Analyst Blog | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 21/02/2013 | 21:12 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 21/02/2013 | 21:00 | Marketwired | Onyx Pharmaceuticals Reports Full Year and Fourth Quarter 2012 Financial Results | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 20/02/2013 | 13:30 | Marketwired | Onyx Pharmaceuticals Announces Carfilzomib Study Published in the Medical Journal Leukemia Study Assessed Impact of Renal Fun... | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 15/02/2013 | 13:30 | Marketwired | Onyx Pharmaceuticals Appoints Dr. Pablo Cagnoni as Executive Vice President, Global Research & Development and Technical Oper... | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 14/02/2013 | 19:21 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 14/02/2013 | 17:52 | Edgar (US Regulatory) | Schedule 13g | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 14/02/2013 | 14:31 | PR Newswire (US) | Critical Alerts For Verizon, United Continental, Garmin, Onyx Pharmaceuticals, and Darden Restaurants Released By InvestorsOb... | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |